Design Therapeutics DSGN
NASDAQ DSGN
$12.57 -0.05 (-0.40%)
At close: Sep 30, 2026 · 4:00 PM EDT

Design Therapeutics (DSGN) Shares Outstanding (Entity) (2020 - 2026)

Updated

Design Therapeutics' Shares Outstanding (Entity) came in at 62.58 million for Q2 2026, up 9.9% from 56.95 million a year earlier and up 0.2% from the prior quarter.

Analysis

Design Therapeutics (DSGN) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

For FY2025, Design Therapeutics' Shares Outstanding (Entity) was 60.4 million, up 6.4% from FY2024.

  • Shares Outstanding (Entity) has increased in each of the last five years, with a five-year compound annual growth rate of 30.5% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 56.75 million in FY2024 (+0.5%), 56.47 million in FY2023 (+1.0%), 55.9 million in FY2022 (+21.7%) and 45.94 million in FY2021 (+187.9%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2020.
  • Year-over-year, Shares Outstanding (Entity) has increased for 22 consecutive quarters, with growth averaging 3.7% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.3% (Q3 2023) and 215.5% (Q1 2022) over the last five years.
  • Business Quant data shows DSGN's Shares Outstanding (Entity) at 62.44 million (Q1 2026), 60.4 million (Q4 2025) and 56.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Design Therapeutics 786.63 Mn -69.40 Mn - 62.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62.58 Mn
Mar 31, 2026 62.44 Mn
Dec 31, 2025 60.40 Mn
Sep 30, 2025 56.96 Mn
Jun 30, 2025 56.95 Mn
Mar 31, 2025 56.77 Mn
Dec 31, 2024 56.75 Mn
Sep 30, 2024 56.62 Mn
Jun 30, 2024 56.62 Mn
Mar 31, 2024 56.49 Mn
Dec 31, 2023 56.47 Mn
Sep 30, 2023 56.00 Mn
Jun 30, 2023 55.98 Mn
Mar 31, 2023 55.92 Mn
Dec 31, 2022 55.90 Mn
Sep 30, 2022 55.84 Mn
Jun 30, 2022 55.72 Mn
Mar 31, 2022 55.62 Mn
Dec 31, 2021 45.94 Mn
Sep 30, 2021 55.22 Mn
API Access

Design Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=DSGN&period=max&api_key=YOUR_API_KEY